FibroGen, Inc. is located at 409 Illinois St, San Francisco, CA 94158. It has around 250 - 500 employees. Its revenue is around $20 - 50M. FibroGen, Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. Its lead product candidate is roxadustat (FG-4592). It is also engaged in developing products, such as FG-6874, FG-3019 and FG-5200. FG-4592 is an oral small molecule inhibitor of hypoxia-inducible factor-prolyl hydroxylases (HIF-PHs), which acts by stimulating the body's natural pathway of erythropoie...
Competitor - 1/8
Which company is more competitive with FibroGen, Inc.?